Hospital Pharmacy

Publications

• Biagini S, La dispensazione dei farmaci ai reparti in regime di day hospital e ai presidi in regime di home care. Ragiufarm, Rassegna Giuridico Farmaceutica, Anno X, n.60, novembre-dicembre 2000: pag. 6-13

• Volpi E, Giannelli A, Mangione M, Baroni M, Tonazzini S, Alduini S, Biagini S, Laws E. Prevenzione degli errori in terapia durante il ricovero ospedaliero attraverso l’utilizzo della STU elettronica. Boll SIFO 2015;61(3):100-104

• Volpi E, Giannelli A, Toccafondi G, Tartaglia R, Micalizzi M, Mangione M, Baroni M, Tonazzini S, Alduini S, Biagini S, Laws E and Bellandi T, Human Factors Approach in the Design of an Electronic Medication Management System for Preventing Inpatient Medication Errors. J of Pharmacovigilance 2015, S2:006

• Volpi E, Giannelli A, Toccafondi G, Baroni M, Tonazzini S, Alduini, S, Biagini S, Gini R, Bellandi T, Emdin M, Medication Reconciliation During Hospitalization and in Hospital-Home Interface: An Observational Retrospective Study. J Patient Saf 2017, Mar 22 [PMID: 28333697]

• Volpi E, Lo Surdo G, Zizevskikh M, Salvadori S, Toccafondi G, Baroni M, Tonazzini S, Alduini S, Gini R, Bellandi T, Maffei S, Biagini S, Proton-pump inhibitor prescriptions in patients with cardiovascular disease: can the medication reconciliation process and the physician-hospital pharmacist teamwork improve adherence to international and national guidelines? GIFAC 2018;32(3):126-132 | DOI 10.1721/2974.29813

• Zizevskikh M, Volpi E, Lo Surdo G, Tonazzini S, Alduini S, Da Valle P, Baratta S, Assanta N, Baroni M, Biagini S, Terapia farmacologica alla dimissione nel paziente pediatrico: un percorso condiviso tra ospedale e territorio a garanzia della sicurezza e della continuità delle cure.GIFAC 2019;33(3):112-118

• Sbrana F, Dal Pino B, Bigazzi F, Ripoli A, Volpi E, Fogliaro MP, Lo Surdo G, Pianelli M, Luciani R, Biagini S, Sampietro T, A large Italian cohort on proprotein convertase subtilisin/kexin type 9 inhibitors. Eur J Prev Cardiol. 2019 Nov 25:2047487319888059. doi: 10.1177/2047487319888059

• Piccinni C, Antonazzo IC, Maggioni AP, Pedrini A, Calabria S, Ronconi G, Letizia Dondi L, Martini N, Roberto G, Sampietro T, Sbrana F, Dal Pino B, Bigazzi F, Lo Surdo G, Volpi E, Biagini S, Gini R, PCSK9 Inhibitors’ New Users: Analysis of Prescription Patterns and Patients’ Characteristics from an Italian Real-world Study. Clin Drug Investigation (2019)

• Aimo A, Cerbai E, Bartolucci G, Adamo L, Barison A, Lo Surdo G, Biagini S, Passino C, Emdin M, Pirfenidone is a Cardioprotective Drug: Mechanisms of Action and Preclinical Evidence, Pharmacological Research, 2020 Feb 12:104694, doi: 10.1016/j.phrs.2020.104694

• Lo Surdo G, Volpi E, Tonazzini S, Alduini S, Salvadori S, Baroni M, Maffei S, Biagini S, Drug-drug interactions and polypharmacy in patients with cardiovascular diseases: the CARD-REC observational retrospective study. GIFAC 2020;34(3):106-113 | doi 10.1721/3442.34308

• Genovesi D, Vergaro G, Giorgetti A, Marzullo A, Scipioni M, Santarelli MF, Pucci A, Buda G, Volpi E, Emdin M, [18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions. JACC Cardiovasc Imaging 2020 Aug 5;S1936-878X(20)30521-0. doi: 10.1016/j.jcmg.2020.05.031